About Akuos Inc.
Akuos develops adeno-associated virus gene therapy products for the treatment of hereditary and acquired sensorineural hearing loss delivered via cochlear infusion.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Akuos Inc.. Response typically within 48 hours.
